This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Feb;96(2):125-127.

doi: 10.1111/imcb.12004. Epub 2018 Jan 20.

Nonclassical monocytes: are they the next therapeutic targets in multiple sclerosis?

Bahareh Ajami¹, Lawrence Steinman¹

Affiliations

PMID: 29352485
DOI: 10.1111/imcb.12004

Comment

Nonclassical monocytes: are they the next therapeutic targets in multiple sclerosis?

Bahareh Ajami et al. Immunol Cell Biol. 2018 Feb.

. 2018 Feb;96(2):125-127.

doi: 10.1111/imcb.12004. Epub 2018 Jan 20.

Authors

Bahareh Ajami¹, Lawrence Steinman¹

Affiliation

¹ Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.

PMID: 29352485
DOI: 10.1111/imcb.12004

No abstract available

PubMed Disclaimer

Comment on

Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis.
Gjelstrup MC, Stilund M, Petersen T, Møller HJ, Petersen EL, Christensen T. Gjelstrup MC, et al. Immunol Cell Biol. 2018 Feb;96(2):160-174. doi: 10.1111/imcb.1025. Epub 2017 Dec 11. Immunol Cell Biol. 2018. PMID: 29363161 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information